We have previously shown the beneficial effects of recombinant peroxiredoxin 6 (Prdx6, EC:1.11.1.27) in various pathologies associated with oxidative stress, such as mechanical and thermal skin injuries, chemical burns of the respiratory tract, ischemia-reperfusion injuries [2,3,4], and type 1 diabetes mellitus [5]. This evidence concerns the gene PRDX6 and diabetes mellitus.